Law360, New York (June 25, 2010, 6:15 PM ET) -- In the first-ever win on jawbone-death claims related to Merck & Co.’s osteoporosis drug Fosamax, jurors awarded $8 million in compensatory damages Friday to bellwether plaintiff Shirley Boles.
Jurors returned a verdict in the U.S. District Court for the Southern District of New York after just a few hours of deliberations, finding the drug to be defectively designed for certain purposes and Merck negligent in failing to address risks associated with the medication.
"This is the world's bravest great-grandmother," Boles' attorney Timothy O'Brien said following the...
Jury Stuns Merck With $8M Verdict For Fosamax Plaintiff
To view the full article, take a free trial now.
